Pro-inflammatory effects of substance P: new perspectives for the treatment of airway diseases?
Joos
G F
GF
Department of Respiratory Diseases, Ghent University Hospital, De Pintelaan 185, B 9000 Ghent, Belgium.
Pauwels
R A
RA
D000276:Adjuvants, Immunologic / Q000378:metabolism; D000818:Animals; D001249:Asthma / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D008173:Lung Diseases, Obstructive / Q000188:drug therapy / Q000378:metabolism*; D018039:Receptors, Tachykinin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013373:Substance P / Q000187:drug effects / Q000378:metabolism*; D015320:Tachykinins / Q000187:drug effects / Q000378:metabolism
D000276:Adjuvants, Immunologic; D018836:Inflammation Mediators; D018039:Receptors, Tachykinin; D015320:Tachykinins; D013373:Substance P